Reduced progression of atherosclerosis in apolipoprotein E‐deficient mice treated with lacidipine is associated with a decreased susceptibility of low‐density lipoprotein to oxidation

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International journal of experimental pathology (Print)

• Publication date

  2004-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.0959-9673.2004.00375.xPMID 15154916PMCID PMC2517459
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis: Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term Trial

  2002cited by this paper
• Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation.

  2001cited by this paper
• Anti-atherosclerotic activity of the calcium antagonist lacidipine in cholesterol-fed hamsters.

  2000influential reference
• The calcium‐channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE‐deficient mouse

  2000influential reference
• The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

  1999cited by this paper
• 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.

  1999influential reference
• Antiatherosclerotic and antioxidative effects of captopril in apolipoprotein E-deficient mice.

  1998cited by this paper
• Oxidative Modification of LDL and Atherogenesis

  1998cited by this paper
• Oxidized low‐density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells: inhibitory effect of lacidipine

  1998cited by this paper
• Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells

  1997cited by this paper
• Plasma LDL oxidation leads to its aggregation in the atherosclerotic apolipoprotein E-deficient mice.

  1997cited by this paper
• Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells.

  1997cited by this paper
• Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis.

  1997cited by this paper
• Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.

  1996cited by this paper
• Mechanisms involved in the in vitro modification of low density lipoprotein by human umbilical vein endothelial cells and copper ions.

  1996influential reference
• Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice.

  1995cited by this paper
• Coantioxidants make alpha-tocopherol an efficient antioxidant for low-density lipoprotein.

  1995cited by this paper
• Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.

  1995cited by this paper
• Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice.

  1994influential reference
• ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

  1994cited by this paper
• The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.

  1994cited by this paper
• Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

  1994cited by this paper
• Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.

  1994cited by this paper
• Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.

  1994cited by this paper
• Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease.

  1993cited by this paper
• Non-enzymatic oxidation of lipids and lipoproteins: the role of metals and nitric oxide

  1993cited by this paper
• Transgenic mouse models of lipoprotein metabolism and atherosclerosis.

  1993cited by this paper
• Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity.

  1992cited by this paper
• Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man.

  1992cited by this paper
• Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

  1992cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• Oxidation of methyl linoleate in aqueous dispersions induced by copper and iron.

  1992cited by this paper
• Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.

  1992cited by this paper
• Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits.

  1991cited by this paper
• Predisposition to LDL oxidation during copper-catalyzed oxidative modification and its relation to alpha-tocopherol content in humans.

  1991influential reference
• Superoxide and peroxyl radical generation from the reduction of polyunsaturated fatty acid hydroperoxides by soybean lipoxygenase.

  1991cited by this paper
• A simple test for predisposition to LDL oxidation based on the fluorescence development during copper-catalyzed oxidative modification.

  1991influential reference
• Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex.

  1991cited by this paper
• Oxidized LDL affects multiple atherogenic cellular responses.

  1991cited by this paper
• Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation.

  1991cited by this paper
• Uptake and degradation of low density lipoproteins in atherosclerotic rabbit aorta: role of local LDL modification.

  1991cited by this paper
• Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma.

  1991cited by this paper
• Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

  1989cited by this paper
• Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin.

  1989cited by this paper
• Vitamin E and other Lipophilic Antioxidants Protect LDL against Oxidation

  1989cited by this paper
• Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.

  1989cited by this paper
• Presence of a Modified Low Density Lipoprotein in Humans

  1988cited by this paper
• Antioxidants in relation to lipid peroxidation.

  1987cited by this paper
• Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes.

  1987cited by this paper
• Measurement of protein using bicinchoninic acid.

  1985cited by this paper

• Tweaking lentiviral vector design balances efficacy and safety in liver-directed gene therapy for familial hypercholesterolemia.

  2025cites this paper
• Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes

  2018cites this paper
• Enzyme-modified non-oxidized LDL (ELDL) induces human coronary artery smooth muscle cell transformation to a migratory and osteoblast-like phenotype

  2018cites this paper
• Short report Open Access

  2015cites this paper
• Effects of dihydropyridine calcium channel blockers on oxidized low-density lipoprotein induced proliferation and oxidative stress of vascular smooth muscle cells

  2012cites this paper
• Proatherogenic Macrophage Activities Are Targeted by the Flavonoid Quercetin

  2012cites this paper
• Anti-atherosclerotic potential of dihydropyridine calcium channel blockers.

  2012cites this paper
• Calcium channel regulation in vascular smooth muscle cells: synergistic effects of statins and calcium channel blockers.

  2010cites this paper
• Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure.

  2010cites this paper
• Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis

  2005cites this paper